HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center

Sung Kwan Bae, Toshifumi Gushima, Noriyuki Saito, Ikumi Yamanaka, Yayoi Matsuo, Shuro Yoshida, Ichiro Kawano, Hideho Henzan, Shinji Shimoda, Tetsuya Eto, Kazuhiro Takahashi

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)629-631
Number of pages3
JournalBone Marrow Transplantation
Volume54
Issue number4
DOIs
Publication statusPublished - Apr 1 2019

All Science Journal Classification (ASJC) codes

  • Hematology
  • Transplantation

Cite this

Bae, S. K., Gushima, T., Saito, N., Yamanaka, I., Matsuo, Y., Yoshida, S., Kawano, I., Henzan, H., Shimoda, S., Eto, T., & Takahashi, K. (2019). HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center. Bone Marrow Transplantation, 54(4), 629-631. https://doi.org/10.1038/s41409-018-0355-6